跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Novazithro - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Novazithro
Approved
STANDARD
Novazithro
S Kant Healthcare Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
83e69d954c04f201
Company
S Kant Healthcare Ltd.
Type
Standard
Approval Details
Approval Id
83e69d954c04f201
Drug Approval Philippines Name
Novazithro
Product Name
Novazithro
Registration Number
DRP-16281
Brand Name
Novazithro
Generic Name
Azithromycin (as dihydrate)
Dosage Form
Powder for Oral Suspension
Dosage Strength
200 mg/5 mL
Manufacturer
S Kant Healthcare Ltd.
Importer
Medinova Pharmaceutical Inc.
Distributor
Medinova Pharmaceutical Inc.
Issuance Date
27 January 2025
Expiry Date
27 January 2030
Pharmacologic Category
Antibacterial (Macrolide)
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
83e69d954c04f201
Type
Standard
Back to Philippines FDA Approvals